| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5845791 | Pulmonary Pharmacology & Therapeutics | 2013 | 7 Pages |
Abstract
Patients previously controlled with FP/S in any device formulation can effectively step-across to extrafine BDP/F pMDI, maintaining lung function and asthma control with a 5-min onset of action.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Neil Barnes, Jan Arie van Noord, Caterina Brindicci, Ludger Lindemann, Guido Varoli, Miguel Perpiña, Daniele Guastalla, Daniela Casula, Shishir Patel, Pascal Chanez,